Sprinklr Announces Fourth Quarter and Full Year Fiscal 2022 Results
Go back to Sprinklr Announces Fourth Quarter and Full Year Fiscal 2022 Results| Cardium Therapeutics, Inc. (NYSE: CXM) | Delayed: 5.38 -0.17 (3.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.55 | 52 Week High | $1.44 | |||
| Open | $5.58 | 52 Week Low | $0.06 | |||
| Day High | $5.63 | P/E | N/A | |||
| Day Low | $5.36 | EPS | $-1.24 | |||
| Volume | 1,180,373 | |||||
